EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.5 | beta-mercaptoethanol | using a redox-inert methyl acceptor, it is shown that BHMT requires a thiol reducing agent for activity. Short-term exposure of BHMT to reducing agent-free buffer inactivates the enzyme without causing any loss of its catalytic zinc. Activity can be completely restored by the re-addition of a thiol reducing agent | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.1.1.5 | C104A | site-directed mutagenesis is used to investigate whether the loss of the DMSA-Asp activity of BHMT when in the absence of a reducing agent is due to the oxidation of an essential thiol within the protein. By individual mutation of each of the five Cys residues not involved in Zn binding to Ala, it is shown that the resulting mutants are as active as wild-type enzyme when in the presence of beta-mercaptoethanol with the DMSA-Asp assay | Homo sapiens |
2.1.1.5 | C131A | site-directed mutagenesis is used to investigate whether the loss of the DMSA-Asp activity of BHMT when in the absence of a reducing agent is due to the oxidation of an essential thiol within the protein. By individual mutation of each of the five Cys residues not involved in Zn binding to Ala, it is shown that the resulting mutants are as active as wild-type enzyme when in the presence of beta-mercaptoethanol with the DMSA-Asp assay | Homo sapiens |
2.1.1.5 | C186A | site-directed mutagenesis is used to investigate whether the loss of the DMSA-Asp activity of BHMT when in the absence of a reducing agent is due to the oxidation of an essential thiol within the protein. By individual mutation of each of the five Cys residues not involved in Zn binding to Ala, it is shown that the resulting mutants are as active as wild-type enzyme when in the presence of beta-mercaptoethanol with the DMSA-Asp assay | Homo sapiens |
2.1.1.5 | C201A | site-directed mutagenesis is used to investigate whether the loss of the DMSA-Asp activity of BHMT when in the absence of a reducing agent is due to the oxidation of an essential thiol within the protein. By individual mutation of each of the five Cys residues not involved in Zn binding to Ala, it is shown that the resulting mutants are as active as wild-type enzyme when in the presence of beta-mercaptoethanol with the DMSA-Asp assay | Homo sapiens |
2.1.1.5 | C256A | site-directed mutagenesis is used to investigate whether the loss of the DMSA-Asp activity of BHMT when in the absence of a reducing agent is due to the oxidation of an essential thiol within the protein. By individual mutation of each of the five Cys residues not involved in Zn binding to Ala, it is shown that the resulting mutants are as active as wild-type enzyme when in the presence of beta-mercaptoethanol with the DMSA-Asp assay | Homo sapiens |
2.1.1.5 | additional information | experiments using the glutamate-cysteine ligase modifier subunit knockout mice Gclm(-/-), which are severely impaired in glutathione synthesis, show that the DMSA-Asp dependent BHMT activity is 75% lower in Gclm(-/-) than Gclm(+/+) mice. The Bet-Hcy dependent BHMT activity is essentially identical between both groups. This results show that the loss of DMSA-Asp dependent activity in Gclm(-/-) is due to the lower level of free thiols in those livers | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.5 | L-Asp | 10 mM Asp inhibits BHMT | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.1.1.5 | 10 | - |
L-Asp | - |
Homo sapiens |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.5 | Zn2+ | wild-type enzyme contains catalytic active zinc which is bound by three thiolates and one hydroxyl group. Long-term exposure of BHMT to reducing agent-free buffer results in the slow, irreversible loss of its catalytic Zn and a corresponding loss of activity | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.5 | Homo sapiens | - |
- |
- |
2.1.1.5 | Mus musculus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.1.1.5 | wild-type and mutant enzymes are overexpressed in Escherichia coli and purified using the ImpactTM T7 system | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.5 | liver | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.5 | L-Asp + dimethylsulfonioacetate | - |
Mus musculus | ? | - |
? | |
2.1.1.5 | L-Asp + dimethylsulfonioacetate | using the non-physiological methyl donor dimethylsulfonioacetate an O-methylation of Asp is performed by BHMT, but only in the presence of beta-mercaptoethanol | Homo sapiens | ? | - |
? | |
2.1.1.5 | L-homocysteine + betaine | - |
Mus musculus | L-methionine + dimethylglycine | - |
? | |
2.1.1.5 | L-homocysteine + betaine | - |
Homo sapiens | L-methionine + dimethylglycine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.5 | betaine-homocysteine S-methyltransferase | - |
Mus musculus |
2.1.1.5 | betaine-homocysteine S-methyltransferase | - |
Homo sapiens |
2.1.1.5 | BHMT | - |
Homo sapiens |